Status:
COMPLETED
Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma
Lead Sponsor:
Eisai Co., Ltd.
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
Brief Summary
This surveillance's objectives are: 1. Unknown adverse reactions 2. Incidences of adverse drug reaction 3. Factors considered to have effect to safety and effectiveness
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients with Hepatocellular carcinoma
- Exclusion criteria:
- None
Exclusion
Key Trial Info
Start Date :
March 6 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 25 2015
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT02269995
Start Date
March 6 2014
End Date
December 25 2015
Last Update
November 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Multiple Locations, Japan